Related references
Note: Only part of the references are listed.Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi et al.
ANTIOXIDANTS (2021)
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
Ferdinando Carlo Sasso et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
Luigi Elio Adinolfi et al.
ATHEROSCLEROSIS (2020)
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study
Luigi E. Adinolfi et al.
DIABETES OBESITY & METABOLISM (2020)
Metabolic liver disease in diabetes - From mechanisms to clinical trials
Bedair Dewidar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Prevalence of diabetes in Poland: a combined analysis of national databases
R. Topor-Madry et al.
DIABETIC MEDICINE (2019)
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
Luca Rinaldi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
Mario Masarone et al.
PLOS ONE (2017)
Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey
Tomasz Zdrojewski et al.
KARDIOLOGIA POLSKA (2013)
Chronic HCV infection: epidemiological and clinical relevance
S. Zaltron et al.
BMC INFECTIOUS DISEASES (2012)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
The global health burden of hepatitis C virus infection
Francesco Negro et al.
LIVER INTERNATIONAL (2011)
Chemerin, vaspin and insulin resistance in chronic hepatitis C
M. Kukla et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels
Ling-Ling Jiang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C
Yasunori Kawaguchi et al.
LIVER INTERNATIONAL (2009)
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
Manuel Romero-Gomez et al.
JOURNAL OF HEPATOLOGY (2008)
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3
Hossein Poustchi et al.
JOURNAL OF HEPATOLOGY (2008)
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C
Christine Bernsmeier et al.
JOURNAL OF HEPATOLOGY (2008)
Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A
Verena Christen et al.
HEPATOLOGY (2007)
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines
Ian Homer Y. Cua et al.
HEPATOLOGY (2007)
Resistin as an intrahlepatic cytokine -: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells
Cristiana Bertolani et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients -: A case-control study
A Lecube et al.
DIABETES CARE (2006)
Hepatitis C infection and diabetes
H Noto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy
R D'Souza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Hepatitis C virus infection-related Type 1 diabetes mellitus
LK Chen et al.
DIABETIC MEDICINE (2005)
Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study
CO Zein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Hepatitis C virus-associated extrahepatic manifestations:: A review
D Sène et al.
METABOLIC BRAIN DISEASE (2004)
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
K Ueki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
FHT Duong et al.
GASTROENTEROLOGY (2004)
Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes
S Aytug et al.
HEPATOLOGY (2003)
Hepatitis C virus infection and incident type 2 diabetes
SH Mehta et al.
HEPATOLOGY (2003)
TNF-α and growth hormone resistance in patients with chronic liver disease
A Picardi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection
T Maeno et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association
H Knobler et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
JM Petit et al.
JOURNAL OF HEPATOLOGY (2001)
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States
SH Mehta et al.
ANNALS OF INTERNAL MEDICINE (2000)
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease
NN Zein et al.
JOURNAL OF HEPATOLOGY (2000)
Liver transplantation and diabetes mellitus
T Steinmuller et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
Share Paper
